Oragenics, Inc. announced that on December 16, 2022 the Board of Directors appointed Charles Pope as its Chairman of the Board of Directors succeeding Dr. Frederick W. Telling, who has served as a director since June 2010 and as Chairman since February 2011. Dr. Telling will remain on the Board as an independent director and as a member of both the audit and nominating and corporate governance committees.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.016 USD | -1.37% | -2.32% | -81.94% |
06-25 | Top Midday Decliners | MT |
05-27 | Certain Series F Non-Voting, Convertible Preferred Stock of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 27-MAY-2024. | CI |
1st Jan change | Capi. | |
---|---|---|
-81.94% | 5.67M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- OGEN Stock
- News Oragenics, Inc.
- Oragenics, Inc. Announces Board Changes